Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suck Chei Choi

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Alimentary Pharmacology & Therapeutics|July 24, 2020
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcerYu Kyung Cho, Myung-Gyu Choi, Suck Chei Choi, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Journal of Neurogastroenterology and Motility|April 3, 2020
2019 Seoul Consensus on Esophageal Achalasia GuidelinesHye-Kyung Jung, Su Jin Hong, Oh Young Lee, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Gut and Liver|January 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric UlcersKyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, et al.
Gastroenterology|April 16, 2020
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global StudyAmi D Sperber, Shrikant I Bangdiwala, Douglas A Drossman, et al.
Journal of Neurogastroenterology and Motility|October 13, 2021
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux DiseaseHye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, et al.
Neurogastroenterology and Motility|April 5, 2023
Face-to-face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population-based researchAmi D Sperber, Serhat Bor, Xuicai Fang, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Alimentary Pharmacology & Therapeutics|July 24, 2020
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcerYu Kyung Cho, Myung-Gyu Choi, Suck Chei Choi, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Journal of Neurogastroenterology and Motility|April 3, 2020
2019 Seoul Consensus on Esophageal Achalasia GuidelinesHye-Kyung Jung, Su Jin Hong, Oh Young Lee, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Gut and Liver|January 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric UlcersKyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh, et al.
Gastroenterology|April 16, 2020
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global StudyAmi D Sperber, Shrikant I Bangdiwala, Douglas A Drossman, et al.
Journal of Neurogastroenterology and Motility|October 13, 2021
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux DiseaseHye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, et al.
Neurogastroenterology and Motility|April 5, 2023
Face-to-face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population-based researchAmi D Sperber, Serhat Bor, Xuicai Fang, et al.
Pageof 17